News Releases
Mar 9 2004
Peregrine Pharmaceuticals Announces Patent Grant for Vascular Targeting Agents That Target Vascular Endothelial Growth Factor
Feb 24 2004
Peregrine Pharmaceuticals Announces Patent Grant For Vasopermeation Enhancement Technology
Feb 6 2004
Peregrine's Vascular Targeting Agent Technology Reviewed In 'Clinical Cancer Research'
Feb 4 2004
Peregrine's Cotara(R) Phase I Hepatic Cancer Study Published In 'Cancer Therapy'
Jan 13 2004
Peregrine Pharmaceuticals Announces Patent Grant For Anti-Angiogenic Treatments Using VEGF Inhibition
Dec 15 2003
Peregrine Pharmaceuticals Announces Patent Grant For Its Phospholipid Vascular Targeting Agent Program
Dec 11 2003
Peregrine Pharmaceuticals Announces European Patent Grant For Vascular Targeting Agents
Dec 11 2003
Peregrine and AERES Biomedical Sign Agreement to Humanize VTA Antibody
Dec 10 2003
Avanir And Peregrine Execute Commercial License Agreement For Anti-Cancer Antibody
Dec 8 2003
Avid Bioservices To Expand Manufacturing Capacity